ATP6AP2 ‐Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.70109 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Alexandre Raynor und 24 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Biochimie métabolique et Cellulaire, Hôpital Bichat, Paris, France. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Genetic Diseases, X-Linked, RNA Splicing. Die Arbeit nennt 49 Literaturangaben. Gefördert von: FWO Senior Postdoctoral Fellowship, Jaeken-Theunissen CDG Fund, FWO-FNRS WEAVE program.
Abstract (Originalsprache)
ATP6AP2 splicing variants cause syndromic X‐linked intellectual disability Hedera type (XPDS; OMIM#300423) and X‐linked parkinsonism with spasticity (MRXSH; OMIM#300911). Alternatively, ATP6AP2 missense variants lead to hepatopathy, immunological abnormalities, cutis laxa and only mild intellectual disability with N‐/O‐glycosylation defects (ATP6AP2‐CDG; OMIM#301045). The disparity between neurological and hepatic ATP6AP2‐related disease entities is an ongoing puzzle. We aimed to investigate whether patients with an isolated neurological presentation of ATP6AP2‐related disease, consistent with XPDS/MRXSH, also have abnormal glycosylation biomarkers, potentially implicating this as part of the pathological mechanism. We identified three males and one female from three families with ATP6AP2 splicing variants and ID/DD, epilepsy, axial hypotonia, axonal neuropathy and microcephaly; the heterozygous female has a milder phenotype. RNA‐Seq in patient‐derived fibroblasts validated defective splicing, correlated with lowered ATP6AP2 protein levels in fibroblasts alongside glycosylation abnormalities. We describe defective glycosylation alongside ATP6AP2 splicing variants in four patients, including the first female with ATP6AP2 ‐related disease. This connects more closely the phenotypes of XPDS/MRXSH and ATP6AP2‐CDG and indicates that abnormal glycosylation markers may be a consistent feature of splicing variants, and potentially part of the pathological mechanism underlying ATP6AP2‐related disease caused by abnormal splicing. We also provide additional evidence that neurodevelopment is uniquely sensitive to the gene dosage of ATP6AP2, linked to the isolated neurological phenotype found in patients with splice variants and the attenuated, but still severe, phenotype of the female in our study. Glycosylation defects can be found in “splicing” forms of ATP6AP2‐related diseases, bridging the gap between XPDS, MRXSH and ATP6AP2‐CDG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AP-HP, Biochimie métabolique et Cellulaire, Hôpital Bichat, Paris, France.
- Paris Cité University, Xavier Bichat Medicine Department, Paris, France.
- Sorbonne Université, AP-HP, Department of Medical Genetics, Paris, France.
- Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Biochemistry and Genetics, Angers University Hospital, Angers, France.
- Translational Metabolic Laboratory, Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
ORCID-Profile: Alexandre Raynor, Jean-Madeleine de Sainte-Agathe, Arnaud Bruneel
Förderung
- FWO Senior Postdoctoral Fellowship
- Jaeken-Theunissen CDG Fund
- FWO-FNRS WEAVE program
- ERA-Net for Research on Rare Diseases
Zitieren
APA
Raynor, A., de Sainte-Agathe, J. M., Post, M. A., Barth, M., Zijlstra, F., Huijben, K., Kouri, I., Couasnard, A., Bellenda, P., Dupré, T., Souche, E., Lebredonchel, E., Cholet, S., Cantaloube, I., Ratier, A., Jacquin, E., Peoc'h, K., Fenaille, F., Matthijs, G., …, & Wilson, M. P. (2025). ATP6AP2 ‐Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70109
Vancouver
Raynor A, de Sainte-Agathe JM, Post MA, Barth M, Zijlstra F, Huijben K, et al. ATP6AP2 ‐Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70109
BibTeX
@article{Raynor2025,
author = {Raynor, Alexandre and de Sainte-Agathe, Jean-Madeleine and Post, Merel A and Barth, Magalie and Zijlstra, Fokje and Huijben, Karin and Kouri, Ioanna and Couasnard, Alexis and Bellenda, Paola and Dupré, Thierry and Souche, Erika and Lebredonchel, Elodie and Cholet, Sophie and Cantaloube, Isabelle and Ratier, Ameetha and Jacquin, Elise and Peoc'h, Katell and Fenaille, François and Matthijs, Gert and Jaeken, Jaak and Bandeira, Anabela and Quelhas, Dulce and Lefeber, Dirk J and Bruneel, Arnaud and Wilson, Matthew P},
title = {ATP6AP2 ‐Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.70109}
}
EUVIMED